J030-0859 Screening compound: ethyl 1-[8-methyl-11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxylate

J030-0859 Screening compound: ethyl 1-[8-methyl-11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxylate
J030-0859 Screening compound: ethyl 1-[8-methyl-11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound J030-0859
ethyl 1-[8-methyl-11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J030-0859

Molecular Formula

C27H33N3O6S (C27 H33 N3 O6 S)

Compound Name

ethyl 1-[8-methyl-11-oxo-2-(piperidinosulfonyl)-10,11-dihydrodibenzo[b,f][1,4]oxazepin-3-yl]-4-piperidinecarboxylate

IUPAC name

ethyl 1-[6-methyl-10-oxo-13-(piperidine-1-sulfonyl)-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(15)3571113-hexaen-14-yl]piperidine-4-carboxylate

SMILES

CCOC(C(CC1)CCN1c(cc(c1c2)Oc(ccc(C)c3)c3NC1=O)c2S(N1CCCCC1)(=O)=O)=O

InChI

InChI=1S/C27H33N3O6S/c1-3-35-27(32)19-9-13-29(14-10-19)22-17-24-20(16-25(22)37(33,34)30-11-5-4-6-12-30)26(31)28-21-15-18(2)7-8-23(21)36-24/h7-8,15-17,19H,3-6,9-14H2,1-2H3,(H,28,31)

InChI Key

ZJUCJIUCEKVDLI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27220413

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

527.64

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.429

Distribution Coefficient, logD

4.383

Water Solubility, LogSw

-4.31

Polar Surface Area

87.956

Acid Dissociation Constant (pKa)

8.35

Base Dissociation Constant (pKb)

-1.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.10

J030-0859 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with J030-0859 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J030-0859?
Check Price and Availability of J030-0859, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J030-0859 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J030-0859
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J030-0859
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J030-0859 available by request